Insider Trading & Ownership of BVF II GP LLC

Location
San Francisco, CA
Summary
The estimated value of insider holdings of BVF II GP LLC is at least $54,790,729 dollars as of 18 May 2026. BVF II GP LLC is the 10%+ Owner of XOMA Royalty Corp and owns shares of XOMA Royalty Corp (XOMA) stock worth about $37.14M. BVF II GP LLC is the Director, 10%+ Owner of MoonLake Immunotherapeutics and owns shares of MoonLake Immunotherapeutics (MLTX) stock worth about $17.65M.
Signature
Mark N. Lampert
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow BVF II GP LLC and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

  • BVF II GP LLC has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $54,790,729.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: XOMA Royalty Corp ($37,142,080).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of BVF II GP LLC

XOMA, XOMAO Forms 3/4/5

XOMA Royalty Corp

Relationship
10%+ Owner
Holdings value
$37,142,080
Past year net change
Change %
Report period
14 May 2026

Insider Transactions Reported by BVF II GP LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .